<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">cardio</journal-id><journal-title-group><journal-title xml:lang="ru">Кардиология</journal-title><trans-title-group xml:lang="en"><trans-title>Kardiologiia</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">0022-9040</issn><issn pub-type="epub">2412-5660</issn><publisher><publisher-name>Kardiomag</publisher-name></publisher></journal-meta><article-meta><article-id custom-type="elpub" pub-id-type="custom">cardio-224</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>RESEARCH ARTICLES</subject></subj-group></article-categories><title-group><article-title>КЛИНИКО-ЭКОНОМИЧЕСКАЯ ЭФФЕКТИВНОСТЬ ПРОВЕДЕНИЯ ЭНДОВАСКУЛЯРНОГО ЛЕЧЕНИЯ КОРОНАРНЫХ АРТЕРИЙ У ПАЦИЕНТОВ СО СТАБИЛЬНОЙ ИШЕМИЧЕСКОЙ БОЛЕЗНЬЮ СЕРДЦА ПРИ ГОСПИТАЛИЗАЦИИ НА «ОДНУ НОЧЬ»</article-title><trans-title-group xml:lang="en"><trans-title>Clinical and cost effectiveness of percutaneous coronary intervention for patients with chronic coronary artery disease during overnight hospitalization</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Басинкевич</surname><given-names>А. Б.</given-names></name><name name-style="western" xml:lang="en"><surname>Basinkevich</surname><given-names>A. B.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Матчин</surname><given-names>Ю. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Matchin</surname><given-names>Yu. G.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Бубнов</surname><given-names>Д. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Bubnov</surname><given-names>D. S.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Сильвестрова</surname><given-names>Г. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Silvestrova</surname><given-names>G. A.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шамрина</surname><given-names>Н. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Shamrina</surname><given-names>N. S.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Атанесян</surname><given-names>Р. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Atanesyan</surname><given-names>R. V.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Данилушкин</surname><given-names>Ю. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Danilushkin</surname><given-names>Yu. V.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Скоробогатова</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Skorobogatova</surname><given-names>A. V.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Агеев</surname><given-names>Ф. Т.</given-names></name><name name-style="western" xml:lang="en"><surname>Ageev</surname><given-names>F. T.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Владимиров</surname><given-names>С. К.</given-names></name><name name-style="western" xml:lang="en"><surname>Vladimirov</surname><given-names>S. K.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБУ «РКНПК» МЗ РФ</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Russian Cardiology Science and Production Center</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФГБОУ ВО «Первый МГМУ имени И.М. Сеченова» МЗ РФ</institution><country>Россия</country></aff><aff xml:lang="en"><institution>I.M. Sechenov First Moscow State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2018</year></pub-date><pub-date pub-type="epub"><day>18</day><month>11</month><year>2018</year></pub-date><volume>58</volume><issue>3S</issue><fpage>36</fpage><lpage>45</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Kardiomag, 2018</copyright-statement><copyright-year>2018</copyright-year><copyright-holder xml:lang="ru">Kardiomag</copyright-holder><copyright-holder xml:lang="en">Kardiomag</copyright-holder><license xlink:href="https://cardio.elpub.ru/jour/about/submissions#copyrightNotice" xlink:type="simple"><license-p>https://cardio.elpub.ru/jour/about/submissions#copyrightNotice</license-p></license></permissions><self-uri xlink:href="https://cardio.elpub.ru/jour/article/view/224">https://cardio.elpub.ru/jour/article/view/224</self-uri><abstract><p>Цель. Оценка клинико-экономической эффективности проведения эндоваскулярного лечения коронарных артерий у больных со стабильным течением ИБС с госпитализацией на «одну ночь». Материалы и методы. С использованием метода анализа «минимизации стоимости» (cost miniminization analysis) были рассчитаны прямые медицинские затраты на проведение эндоваскулярного лечения коронарных артерий у больных со стабильной ИБС при госпитализации на «одну ночь» в сравнении с «классической» госпитализацией. Результаты. В соответствии с полученными результатами, с экономической точки зрения, наиболее эффективной стратегией госпитализации больных для проведения чрескожного коронарного вмешательства (ЧКВ) со стентированием оказалась госпитализация на «одну ночь». Выявлено, что различия в прямых медицинских затратах (DMC) между двумя группами больных явились статистически значимыми (p=0,01) в пользу группы больных, госпитализированных на «одну ночь». Заключение. Применение схемы госпитализации больных со стабильной ИБС для проведения ЧКВ со стентированием на «одну ночь» повышает экономическую эффективность за счет уменьшения койко-дня и сопровождается снижением расходов на содержание больного в стационаре, приводя к значительной экономии финансов (А между схемами госпитализации составила 21,2% в пользу госпитализации на «одну ночь»). Подобная А свидетельствует о высокой клиникоэкономической эффективности выбранного подхода.</p></abstract><trans-abstract xml:lang="en"><p>Aim. To evaluate cost effectiveness of coronary endovascular treatment in patients with stable IHD during “one-night” hospitalization. Materials and methods. Using the cost-minimization analysis direct medical cost of coronary endovascular treatment in patients with stable IHD during the “one-night” hospitalization was compared with the “classic” hospitalization. Results. The most cost-effective strategy for hospitalization of patients for transcutaneous coronary intervention (TCI) with stenting was the “one-night” hospitalization. Differences in direct medical costs (DMC) were statistically significant (p=0.01) in favor of the patient group hospitalized for one night. Conclusion. The “one-night” hospitalization plan for patients with stable IHD to undergo TCI with stenting increases the cost-effectiveness due to the decreased number of days of stay in the hospital and the associated decrease in cost of in-patient maintenance, which resultes in considerable financial savings (А between the hospitalization plans was 21.2% in favor of the “one-might” hospitalization). This А indicates high cost effectiveness of the selected approach.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>клинико-экономическая эффективность</kwd><kwd>прямые медицинские затраты</kwd><kwd>госпитализация на «одну ночь»</kwd><kwd>чрескожное коронарное вмешательство</kwd><kwd>cost effectiveness</kwd><kwd>direct medical costs</kwd><kwd>overnight hospitalization</kwd><kwd>transcutaneous coronary intervention</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Гиляревский С. Р., Орлов В.А. Использование анализа эффективности лечения для принятия клинического решения в кардиологии. Кардиология. 1997; 37 (9): 70-80.</mixed-citation><mixed-citation xml:lang="en">Гиляревский С. Р., Орлов В.А. Использование анализа эффективности лечения для принятия клинического решения в кардиологии. Кардиология. 1997; 37 (9): 70-80.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Drummond M/F. Resource allocation decisions in health care: a role for quality of life assessments? J Chronic Dis. 1987: 40 (6): 60 5-1 9.</mixed-citation><mixed-citation xml:lang="en">Drummond M/F. Resource allocation decisions in health care: a role for quality of life assessments? J Chronic Dis. 1987: 40 (6): 60 5-1 9.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">O’Brien B. Principles of economic evaluation for health care programs. J Rheumatol. 1995; 22 (7): 1399-402.</mixed-citation><mixed-citation xml:lang="en">O’Brien B. Principles of economic evaluation for health care programs. J Rheumatol. 1995; 22 (7): 1399-402.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Шаповалова M.А., Корецкая Л.P. Организация стационарной медицинской помощи в неврологической практике как медикоэкономическая проблема. Кубанский научный медицинский вестник. 2011; (2): 183-6.</mixed-citation><mixed-citation xml:lang="en">Шаповалова M.А., Корецкая Л.P. Организация стационарной медицинской помощи в неврологической практике как медикоэкономическая проблема. Кубанский научный медицинский вестник. 2011; (2): 183-6.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Flack J.M., Novikov S.V., Ferrario C.M. Benefits of adherence to anti-hypertensive drug therapy. Eur Heart J. 1996; 17 Suppl A: 16-20.</mixed-citation><mixed-citation xml:lang="en">Flack J.M., Novikov S.V., Ferrario C.M. Benefits of adherence to anti-hypertensive drug therapy. Eur Heart J. 1996; 17 Suppl A: 16-20.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Авксентьева М.В., Воробьев П.А., Герасимов В.Б., Горохова С.Г. Экономическая оценка эффективности лекарственной терапии (фармакоэкономический анализ). - М.: ООО «Медикотехнологическое предприятие «Ньюдиамед»; 2000. 80 с.</mixed-citation><mixed-citation xml:lang="en">Авксентьева М.В., Воробьев П.А., Герасимов В.Б., Горохова С.Г. Экономическая оценка эффективности лекарственной терапии (фармакоэкономический анализ). - М.: ООО «Медикотехнологическое предприятие «Ньюдиамед»; 2000. 80 с.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Avxentieva M., Vorobjov P., Sura M. PCV38 Costs of myocardial infarction treatment in Russian Federation. Value in Health. 2004; 7(6): 696-7. DOI: 10.1016/S1098-3015 (10) 65820-2</mixed-citation><mixed-citation xml:lang="en">Avxentieva M., Vorobjov P., Sura M. PCV38 Costs of myocardial infarction treatment in Russian Federation. Value in Health. 2004; 7(6): 696-7. DOI: 10.1016/S1098-3015 (10) 65820-2</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Maron D.J. Nonlipid primary and secondary prevention strategies for coronary heart disease. Clin Cardiol. 1996; 19 (5): 419-23.</mixed-citation><mixed-citation xml:lang="en">Maron D.J. Nonlipid primary and secondary prevention strategies for coronary heart disease. Clin Cardiol. 1996; 19 (5): 419-23.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Синьков М.А., Ваккосов К.М., Шилов А.А., Синьков А.А., Ганюков В.И., Барбараш О.Л. и др. Оценка клинико-экономической эффективности применения методики измерения фракционного резерва кровотока в лечении больных ИБС. Комплексные проблемы ССЗ. 2016; 5 (4): 33-8.</mixed-citation><mixed-citation xml:lang="en">Синьков М.А., Ваккосов К.М., Шилов А.А., Синьков А.А., Ганюков В.И., Барбараш О.Л. и др. Оценка клинико-экономической эффективности применения методики измерения фракционного резерва кровотока в лечении больных ИБС. Комплексные проблемы ССЗ. 2016; 5 (4): 33-8.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Walley T. Drugs, money and society. Br J Clin Pharmacol. 1995; 39 (4): 343-5.</mixed-citation><mixed-citation xml:lang="en">Walley T. Drugs, money and society. Br J Clin Pharmacol. 1995; 39 (4): 343-5.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Doubilet P., Weinstein M.C., McNeil B.J. Use and misuse of the term «Cost Effective» in medicine. New England Journal of Medicine. 1986; 314 (4): 253-6. DOI: 10.1056/NEJM198601233140421</mixed-citation><mixed-citation xml:lang="en">Doubilet P., Weinstein M.C., McNeil B.J. Use and misuse of the term «Cost Effective» in medicine. New England Journal of Medicine. 1986; 314 (4): 253-6. DOI: 10.1056/NEJM198601233140421</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Jönsson B. Measurement of health outcome and associated costs in cardiovascular disease. Eur Heart J. 1996; 17 Suppl A: 2-7.</mixed-citation><mixed-citation xml:lang="en">Jönsson B. Measurement of health outcome and associated costs in cardiovascular disease. Eur Heart J. 1996; 17 Suppl A: 2-7.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Bowling A. Research methods in health: investigating health and health services. 3. ed., repr. -Maidenhead: Open Univ. Press; 2010. 525 с. ISBN: 978-0-335-23364-9</mixed-citation><mixed-citation xml:lang="en">Bowling A. Research methods in health: investigating health and health services. 3. ed., repr. -Maidenhead: Open Univ. Press; 2010. 525 с. ISBN: 978-0-335-23364-9</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Erhardt L., Ball S., Andersson F., Bergentoft P., Martinez C. Cost effectiveness in the treatment ofheart failure with ramipril. A Swedish substudy of the AIRE study. Acute Infarction Ramipril Efficacy. Pharmacoeconomics. 1997; 12 (2 Pt 2): 256-66.</mixed-citation><mixed-citation xml:lang="en">Erhardt L., Ball S., Andersson F., Bergentoft P., Martinez C. Cost effectiveness in the treatment ofheart failure with ramipril. A Swedish substudy of the AIRE study. Acute Infarction Ramipril Efficacy. Pharmacoeconomics. 1997; 12 (2 Pt 2): 256-66.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Sheffield R.E., Sullivan S.D., Saltiel E., Nishimura L. Cost comparison of rcombinant human erythropoietin and blood transfusion in cancer chemotherapy-induced anemia. Annals of Pharmacotherapy. 1997; 31 (1): 15-22. DOI: 10.1177/106002809703100101</mixed-citation><mixed-citation xml:lang="en">Sheffield R.E., Sullivan S.D., Saltiel E., Nishimura L. Cost comparison of rcombinant human erythropoietin and blood transfusion in cancer chemotherapy-induced anemia. Annals of Pharmacotherapy. 1997; 31 (1): 15-22. DOI: 10.1177/106002809703100101</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
